ALLMedicine™ Anklyosing Spondylitis Center
Research & Reviews 1 results
Rheumatic Diseases Clinics of North America; Song IH, Maksymowych WP
Oct 23rd, 2012 - Tumor necrosis factor α inhibitors (TNF blockers) have revolutionized the treatment of patients with anklyosing spondylitis. Despite clinical efficacy, there are questions and controversies treating rheumatologists face, which this review discusse...
News 1 results
Jun 9th, 2016 - LONDON, United Kingdom — The oral Janus kinase (JAK) inhibitor tofacitinib (Xeljanz, Pfizer) might be a new option for patients with ankylosing spondylitis, according to results from a new phase 2 study. "This is the first study to demonstrate the...